Related Experiment Video
Updated: Aug 27, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Novel Pathogenic Variant (c.1171A>T) in PHF21A in a Female with Intellectual Disability and Craniofacial Anomalies
Cheonghwa Lee1, Jung Yoon1, Borae G Park1
1Department of Laboratory Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
Insights
This study reports a novel variant in the PHF21A gene, expanding the known phenotypes associated with Potocki-Shaffer syndrome (PSS). The findings contribute to a better understanding of PHF21A haploinsufficiency and its clinical spectrum.
Area of Science:
- Genetics
- Developmental Biology
- Medical Genetics
Background:
- PHF21A is a causative gene for Potocki-Shaffer syndrome (PSS), a rare disorder affecting chromosome region 11p11.2.
- PHF21A variants are linked to intellectual disability and craniofacial anomalies, with potential for broader phenotypic expression.
- Limited global case reports necessitate further exploration of PHF21A variants and their associated phenotypes.
Purpose of the Study:
- To report a novel PHF21A variant in a Korean female patient.
- To characterize the extended phenotypic spectrum associated with PHF21A haploinsufficiency.
- To contribute to the understanding of Potocki-Shaffer syndrome genetics.
Main Methods:
- Clinical manifestations were documented.
- Comprehensive assessments included physical examination, cognitive evaluation, brain imaging, metabolic screening, and cytogenetic testing.
- Whole exome sequencing (WES) was performed to identify genetic variants.
Main Results:
- Whole exome sequencing identified a de novo nonsense variant (c.1171A>T, p.Lys391Ter) in the PHF21A gene, affecting the AT-hook domain.
- The patient presented with an extended phenotype including intellectual developmental disorders, craniofacial anomalies, ADHD, epilepsy, overgrowth, and hypotonia.
- The observed phenotypic spectrum aligns with previously reported cases, despite the rarity of AT-hook domain variants in PSS.
Conclusions:
- This case reinforces and expands the known phenotypic spectrum associated with PHF21A haploinsufficiency.
- The findings highlight the importance of considering PHF21A in patients with complex developmental disorders.
- Further research is warranted to fully elucidate the genotype-phenotype correlations of PHF21A variants.
Background:
PHF21A, along with EXT2 and ALX4, is one of the causative genes of Potocki-Shaffer syndrome (PSS), a rare contiguous disorder involving chromosome region11p11.2. PHF21A has been associated with intellectual developmental disorders and craniofacial anomalies and suggested as a candidate for more extended phenotypes. However, variants in PHF21A and its associated phenotypes are yet to be fully explored, since reports on cases with variants affecting this gene are few worldwide. We present a novel heterogeneous variant in PHF21A in a 26-year-old Korean female.
Methods:
The patient's clinical manifestations were recorded and physical examination, cognitive assessment, brain imaging, metabolic screening, and cytogenetic testing including whole exome sequencing were pursued.
Results:
Whole exome sequencing identified a de novo nonsense variant c.1171A>T (p.Lys391Ter), affecting the AT-hook domain. The patient showed an extended phenotypic spectrum along with intellectual developmental disorders and craniofacial anomalies, such as attention-deficit hyperactivity disorder, epilepsy, overgrowth, and hypotonia. Variants affecting the AT-hook domain are few in PSS, however, the phenotypic spectrum of the patient was in line with previously reported cases.
Conclusion:
This case further reinforced and adds to the extended data on the phenotypes associated with PHF21A haploinsufficiency.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Single Nucleotide Polymorphisms-SNPs
Point and Frameshift Mutations
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pleiotropy
Genetic Lingo

